{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:47:51Z","timestamp":1781059671907,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.neuropharm.2007.01.018","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T12:16:34Z","timestamp":1172060194000},"page":"1396-1402","source":"Crossref","is-referenced-by-count":38,"title":["Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: Mediation by Y2 receptors"],"prefix":"10.1016","volume":"52","author":[{"given":"Adepero Shola","family":"Adewale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Macarthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Westfall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.01.018_bib1","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/j.1476-5381.1995.tb15060.x","article-title":"Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226","volume":"116","author":"Aboounader","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.regpep.2005.01.005","article-title":"Neuropeptide Y induced modulation of dopamine synthesis in the striatum","volume":"129","author":"Adewale","year":"2005","journal-title":"Reg. Pept."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/306584a0","article-title":"Neuropeptide Y distribution in human brain","volume":"306","author":"Adrain","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.01.018_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0165-1838(83)90013-9","article-title":"Neuropeptide Y in the adrenal gland","volume":"9","author":"Allen","year":"1983","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.1990.tb48931.x","article-title":"Neuropeptide Y in cortex and striatum","volume":"611","author":"Aoki","year":"1990","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-8993(97)00283-7","article-title":"Differential modulation of NMDA stimulated [3H]dopamine release from rat striatum by neuropeptide Y and \u03b4 receptor ligands","volume":"760","author":"Ault","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-3565(24)37286-6","article-title":"Modulation of [3H]dopamine release from rat nucleus accummbens by neuropeptide Y may involve a sigma1-like receptor","volume":"284","author":"Ault","year":"1998","journal-title":"J. Pharmacol. Exp Ther."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0304-3940(86)90267-3","article-title":"The effect of neuropeptide Y on striatal catecholaimines","volume":"71","author":"Beal","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1073\/pnas.62.3.741","article-title":"Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat","volume":"62","author":"Besson","year":"1969","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00501867","article-title":"In vivo continuous estimation of 3H-DA synthesis and release in the cat caudate nucleus: effects of \u03b1-MPT and transaction of the nigro neostriatal pathway","volume":"278","author":"Besson","year":"1973","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0167-0115(93)90257-9","article-title":"The rabbit saphenous vein: a tissue preparation specifically enriched in NPY-Y1 receptor subtype","volume":"46","author":"Cadieux","year":"1993","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0006-8993(85)90880-7","article-title":"Neuropeptide Y reduced orthodromically evoked population spike in rat hippocampal CA2 by a possibly presynaptic mechanism","volume":"346","author":"Colmers","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib13","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1523\/JNEUROSCI.08-10-03827.1988","article-title":"Neuropeptide Y action in the hippocampal slice: site and mechanism of presynaptic inhibition","volume":"8","author":"Colmers","year":"1988","journal-title":"J.\u00a0Neurosci."},{"issue":"12","key":"10.1016\/j.neuropharm.2007.01.018_bib14","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI4188","article-title":"Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor","volume":"102","author":"Criscione","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"issue":"2","key":"10.1016\/j.neuropharm.2007.01.018_bib15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/en.134.2.719","article-title":"Effects of differentiation on neuropeptide Y receptors and responses in rat phoechromocytoma cells","volume":"134","author":"DiMaggio","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2007.01.018_bib16","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(99)00650-0","article-title":"BIIE0246: a selective and high affinity neuropeptide Y Y2 receptor antagonist","volume":"384","author":"Doods","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0014-2999(93)90502-9","article-title":"Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2, and Y3 receptor subtypes","volume":"238","author":"Dumont","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0703162","article-title":"BIIE0246-A potent and highly selective non-peptide neuropeptide Y Y2 antagonist","volume":"129","author":"Dumont","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1139\/y99-119","article-title":"Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIBO 3304 (Y1) and CGP71683A (Y5)","volume":"78","author":"Dumont","year":"2000","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0167-0115(84)90064-8","article-title":"Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers","volume":"8","author":"Ekblad","year":"1984","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0143-4179(94)90095-7","article-title":"The effects of neuropeptides on the release of neurotransmitter amino acids from rat striatum","volume":"26","author":"Ellis","year":"1994","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2007.01.018_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0306-4522(84)90036-8","article-title":"Differential co-existence of neuropeptide Y (NPY) immunoreactivity with catecholamines in the central nervous system of the rat","volume":"11","author":"Everitt","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.01.018_bib23","series-title":"Handbook of Psychopharmacology 3","first-page":"139","article-title":"Properties and functions of intraneuronal monoamine compartments in central aminergic neurons","author":"Glowinski","year":"1975"},{"key":"10.1016\/j.neuropharm.2007.01.018_bib24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-4159.1966.tb09873.x","article-title":"Regional studies pf catecholamines in the rat brain-I. The disposition of (3H)-norepinephrine, (3H)-dopamine and (3H)-DOPA in various regions of the brain","volume":"13","author":"Glowinski","year":"1966","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2007.01.018_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","article-title":"Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia","volume":"41","author":"Grace","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.01.018_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1476-5381.1994.tb17055.x","article-title":"Neuropeptide Y inhibits potassium stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro","volume":"113","author":"Greber","year":"1994","journal-title":"Br. J. Pharamacol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/cne.902570207","article-title":"Action and location of neuropeptide tyrosine (Y) on hippocampal neurons of the rat in slice prepearation","volume":"257","author":"Haas","year":"1987","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01245130","article-title":"Effects of centrally administered neuropeptide Y and NPY13-36 on the brain monoaminergic system of the rat","volume":"79","author":"Heilig","year":"1990","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0361-9230(92)90178-Z","article-title":"Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in rat striatum","volume":"28","author":"Kerkerian-Le-Goff","year":"1992","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib30","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1152\/jn.1997.78.3.1651","article-title":"Neuropeptide Y suppresses epileptic-form activity in rat hippocampus in vitro","volume":"78","author":"Klapstein","year":"1997","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01352-8","article-title":"XVI. International union of pharmacology recommendations for the nomenclatur of NPY, PYY PP receptors","volume":"50","author":"Michel","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib32","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/S0021-9258(18)93832-9","article-title":"Tyrosine hydroxylase","volume":"239","author":"Nagatsu","year":"1964","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(97)89656-2","article-title":"The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y","volume":"327","author":"Pheng","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1471-4159.2001.00560.x","article-title":"Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat receptor hippocampus:differential effects in CA1, CA3 and dendate gyrus","volume":"79","author":"Silva","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y-A novel brain peptide with structural similarities to peptide YY and pancreatic peptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.01.018_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0014-2999(96)00921-1","article-title":"Modulation of [3H]Dopamine release by neuropeptide Y in rat striatal slices","volume":"321","author":"Tsuda","year":"1997","journal-title":"Eur. J. Pharamcol."},{"issue":"2","key":"10.1016\/j.neuropharm.2007.01.018_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0304-3940(87)90010-3","article-title":"Neuropeptide Y\u00a0alters monoamine turnover in the rat brain","volume":"73","author":"Vallejo","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib38","first-page":"147","article-title":"Cholecystokinin octapeptides alter the release of endogenous dopamine from rat nucleus accumbens in vitro","volume":"237","author":"Voigt","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0304-3940(89)90667-8","article-title":"Ultrastructural correlates of functional relationship between nigral dopaminergic or cortical afferent fibers and neuropeptide Y- containing neurons in the rat striatum","volume":"100","author":"Vuillet","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0167-0115(86)90048-0","article-title":"Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides","volume":"13","author":"Wahlestedt","year":"1986","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0014-2999(00)00478-7","article-title":"Effects of neuropeptide Y Y2 receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices","volume":"404","author":"Weiser","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib42","first-page":"138","article-title":"Prejunctional effects of neuropeptide Y and its role as a cotransmitter","volume":"vol. 162","author":"Westfall","year":"2004"},{"key":"10.1016\/j.neuropharm.2007.01.018_bib43","first-page":"149","article-title":"The effect of cyclic nucleotides on the release of 3H-Dopamine from rat striatal slices","volume":"199","author":"Westfall","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(99)01302-5","article-title":"Neuropeptide Y inhibits glutamate release and long-term potentiation in rat dentate gyrus","volume":"827","author":"Whittaker","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.01.018_bib45","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bjp.0702084","article-title":"Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO3304 and its effect on feeding in rodents","volume":"125","author":"Wieland","year":"1998","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807000433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807000433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T23:53:50Z","timestamp":1736812430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807000433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0028390807000433"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.01.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}